| Time |
Event |
 |
| 8:00 – 8:30 AM |
Continental Breakfast |
|
| 8:30 – 9:20 AM |
Single Use Facilities for Manufacture of Vaccines
Geoffrey Hodge
Bioprocess Technology Leader, Co-founder Xcellerex, GEHC Life Sciences |
|
| 9:20 – 10:10 AM |
NUTS: The Challenge of Technical Life Cycle Management
Alain Pralong
Vice President, New Product Introduction and Technical Life Cycle Management, GlaxoSmithKline |
|
| 10:10 – 10:25 AM |
Coffee Break |
|
| 10:25 – 11:15 AM |
Development of Capsular Polysaccharide Conjugate Vaccines
Stephen A. Kolodziej
Associate Research Fellow-Group Leader, Pfizer, Inc. |
|
| 11:15 AM – 12:05 PM |
Characterization of Vaccines and Biocomparability
Indresh Srivastava
Vice President, Product Realization, Protein Sciences |
|
| 12:05 – 1:00 PM |
Networking Lunch
|
|
| 1:00 – 1:30 PM |
Pre-competitive Consortia in Biomanufacturing: Activities of the MIT Consortium on Adventitious Agent Contamination in Biomanufacturing
Stacy L. Springs
Director, Biomanufacturing Program; Executive Director, CAACB; MIT |
|
| 1:30 – 2:20 PM |
Quality Control of Human Viral Vaccines
Martin Wisher
Senior Director, Quality Assurance and Regulatory Affairs, BioReliance |
|
| 2:20 – 3:10 PM |
Influenza Vaccine and Manufacturing
René Labutut
Vice President, Global Manufacturing Technology, sanofi pasteur |
|
| 3:10 – 3:25 PM |
Short Break
|
|
| 3:25 – 5:00 PM |
Challenges with the Development and Commercialization of Live, Attenuated Influenza Vaccine
Dave Clark
Vice President, Global Technical Operations, AstraZeneca |
|
| 5:30 – 6:30 PM |
Cocktail Reception
Koch Institute Public Galleries
MIT Koch Institute for Integrative Cancer Research
500 Main Street, Cambridge, MA |
|
| 6:30 PM |
Dinner on your own
|
|
|
